Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Simethicone on length of stay in gynecologic patients (Thai)
TCTR20210204012Phase 4Completed
- Sponsor
- Kanchanok Taemamu
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of simethicone in None, sponsored by Kanchanok Taemamu. Primary endpoint: Length of hospital stay. Started Feb 2021; status: completed.
02
Drugs
simethicone
Beyond the preview
Go deeper on TCTR20210204012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210204012.